Related Experiment Video

Updated: Aug 19, 2026

Implantation of a Carotid Cuff for Triggering Shear-stress Induced Atherosclerosis in Mice
07:51

Implantation of a Carotid Cuff for Triggering Shear-stress Induced Atherosclerosis in Mice

Published on: January 13, 2012

Carotid atherosclerosis: is it treatable?

Yuk-Keung Lo

    Journal of the Chinese Medical Association : JCMA
    |March 12, 2005
    PubMed

    Insights

    Flow-mediated dilation (FMD) assesses endothelial dysfunction, a cause of carotid atherosclerosis. Atorvastatin therapy reverses this dysfunction and inflammation within 4-8 months, offering a treatment for atherosclerosis.

    Area of Science:

    • Cardiovascular Medicine
    • Vascular Biology
    • Pharmacology

    Background:

    • Endothelial dysfunction and inflammation are key drivers of carotid atherosclerosis.
    • Brachial-artery flow-mediated dilation (FMD) is a validated noninvasive method to assess endothelial function.

    Discussion:

    • Atorvastatin therapy demonstrates efficacy in reversing endothelial dysfunction within 4 months.
    • Prolonged atorvastatin treatment (over 4 months) may yield significant anti-inflammatory benefits.

    Key Insights:

    • Statin therapy, specifically atorvastatin, can effectively treat carotid atherosclerosis.
    • FMD assessment provides a reliable metric for monitoring treatment response.

    Outlook:

    • Further research could explore optimal statin durations for maximal anti-atherosclerotic effects.
    • Investigating the combined impact of anti-inflammatory and endothelial-restoring properties of statins in atherosclerosis is warranted.

    Related Concept Videos

    Atherosclerosis III: Management01:26

    Atherosclerosis III: Management

    Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
    Atherosclerosis IV: Nursing Management01:23

    Atherosclerosis IV: Nursing Management

    Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
    Coronary Artery Disease V: Interprofessional Care01:27

    Coronary Artery Disease V: Interprofessional Care

    Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
    Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

    Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

    Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
    Coronary Artery Disease IV: Preventive Measures01:26

    Coronary Artery Disease IV: Preventive Measures

    Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
    Angina IV: Management01:26

    Angina IV: Management

    IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...